Clay Siegall is one of the most influential names in the genetics industry. He strongly believes that genetics can help open doors for doctors around the world. He thinks that genetic therapy can cure cancer and several other diseases. Clay is extremely insightful and he is well-respected throughout the biotechnology field.
Siegall founded Seattle Genetics in the late nineties. When he started the company his goal was to develop antibody-based treatments. His leadership has allowed the company to develop several antibody-based therapies to meet the needs of cancer patients. These therapies have been extremely effective and have led to a greater quality of life for cancer patients everywhere. Seattle Genetics launched their first product, ADCETRIS, in 2011. The company now has a large pipeline of therapies set to come out in the coming years. Siegall believes that the company should work closely with other biotechnology companies to produce the best possible products. He wants to best serve patients around the world, and he knows that collaboration is the key to properly serving patients throughout the world.
Siegall loves working with other biotechnology companies. Recently, Siegall was appointed to the board of directors for Mirna Therapeutics. Mirna is a biotechnology company based in Austin. They primarily focus on developing microRNA therapies. Their therapies are extremely impactful, but they want as much insight as possible. Clay Siegall will bring years of medical experience to the company, and he hopes to lead them to new heights.
Clay also serves on the Ultragenyx board. Ultragenyx is an extremely powerful pharmaceutical company. They added Siegall to their board two year ago, and they are extremely happy to have his insight on their board. Clay has years of experience working with biotechnology, and he wants to help Ultragenyx develop new technologies that will help patients. His collaborative personality has been a major asset for the company.
Genetics can cure many different diseases, and Seattle Genetics intends to play a huge role in these cures. They have unveiled several successful products and they intend to keep revealing products for years to come. Clay Siegall is a brilliant leader and he will work with Seattle Genetics for years to come.